PBE icon

Invesco Biotechnology & Genome ETF
PBE

Overview Fund Activity

103 hedge funds and large institutions have $77.6M invested in Invesco Biotechnology & Genome ETF in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 14 increasing their positions, 28 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
+17
Holders Change %
+19.77%
% of All Funds
1.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
14
Reduced
28
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$1.77M
2
Morgan Stanley
2
Morgan Stanley
New York
$13.3M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$1.08M
4
Goldman Sachs
4
Goldman Sachs
New York
$471K
5
Cetera Investment Advisers
5
Cetera Investment Advisers
Illinois
$349K

Top Sellers

1
CW
1
CreativeOne Wealth
Kansas
$1.2M
2
WWM
2
Western Wealth Management
Colorado
$0
3
Wells Fargo
3
Wells Fargo
California
$4.89M
4
Envestnet Asset Management
4
Envestnet Asset Management
Illinois
$535K
5
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$3.66M
Name Holding Trade Value Shares
Change 		Shares
Change %
BAM
101
Baldrige Asset Management
Pennsylvania
$1K – – –
CAS
102
Coppell Advisory Solutions
Texas
$825 +$825 +13 New
CASC
103
Coppell Advisory Solutions Corp
Texas
$825 +$825 +13 New
HNB
104
Huntington National Bank
Ohio
$64 – – –
WWM
105
Western Wealth Management
Colorado
– -$258K -4,390 Closed
LDFR
106
Lehman & Derafelo Financial Resources
Pennsylvania
– -$18K -300 Closed
BCMLT
107
Beacon Capital Management LLC (Tennessee)
Tennessee
– -$1K -22 Closed
1 2 3 4
5